The effects of ketonemia on the course of epilepsy
For type 2 diabetes with neuropathy, medical records must contain specific information that establishes both the diagnosis and the direct relationship between the metabolic disorder and neurological complications
In the longer term, though, it notes that patients may need to switch to compounded semaglutide
It is intended solely for laboratory use and in vitro studies, not for human or animal consumption
Handling Precautions: Handle exclusively in a controlled laboratory environment by trained personnel
- Participants in the semaglutide group achieved a weight loss of at least 5%, 10%, or 15%, and improvements in secondary endpoints, such as waist circumference, blood pressure, and lipid levels, compared to the placebo group